BRCA1 MUTATIONS IN PRIMARY BREAST AND OVARIAN CARCINOMAS

被引:1096
|
作者
FUTREAL, PA
LIU, QY
SHATTUCKEIDENS, D
COCHRAN, C
HARSHMAN, K
TAVTIGIAN, S
BENNETT, LM
HAUGENSTRANO, A
SWENSEN, J
MIKI, Y
EDDINGTON, K
MCCLURE, M
FRYE, C
WEAVERFELDHAUS, J
DING, W
GHOLAMI, Z
SODERKVIST, P
TERRY, L
JHANWAR, S
BERCHUCK, A
IGLEHART, JD
MARKS, J
BALLINGER, DG
BARRETT, JC
SKOLNICK, MH
KAMB, A
WISEMAN, R
机构
[1] MYRIAD GENET,SALT LAKE CITY,UT 84108
[2] UNIV UTAH,MED CTR,DEPT MED INFORMAT,SALT LAKE CITY,UT 84123
[3] FAC HLTH SCI LINKOPING,DEPT OCCUPAT MED,S-58185 LINKOPING,SWEDEN
[4] MEM SLOAN KETTERING CANC CTR,DEPT HUMAN GENET,NEW YORK,NY 10021
[5] DUKE UNIV,MED CTR,DEPT GYNECOL ONCOL,DURHAM,NC 27710
[6] DUKE UNIV,MED CTR,DEPT SURG,DURHAM,NC 27710
关键词
D O I
10.1126/science.7939630
中图分类号
O [数理科学和化学]; P [天文学、地球科学]; Q [生物科学]; N [自然科学总论];
学科分类号
07 ; 0710 ; 09 ;
摘要
Loss of heterozygosity data from familial tumors suggest that BRCA1, a gene that confers susceptibility to ovarian and early-onset breast cancer, encodes a tumor suppressor. The BRCA1 region is also subject to allelic loss in sporadic breast and ovarian cancers, an indication that BRCA1 mutations may occur somatically in these tumors. The BRCA1 coding region was examined for mutations in primary breast and ovarian tumors that show allele loss at the BRCA1 locus. Mutations were detected in 3 of 32 breast and 1 of 12 ovarian carcinomas; all four mutations were germline alterations and occurred in early-onset cancers. These results suggest that mutation of BRCA1 may not be critical in the development of the majority of breast and ovarian cancers that arise in the absence of a mutant germline allele.
引用
收藏
页码:120 / 122
页数:3
相关论文
共 50 条
  • [1] BRCA1 mutations in women with double primary breast and ovarian cancer
    Lalloo, F
    Redmond, E
    Wu, CL
    Cochrane, S
    Elles, R
    Evans, DGR
    JOURNAL OF MEDICAL GENETICS, 1999, 36 : S40 - S40
  • [2] Secondary BRCA1 mutations in BRCA1-mutated ovarian carcinomas with platinum resistance
    Swisher, Elizabeth M.
    Sakai, Wataru
    Karlan, Beth Y.
    Wurz, Kaitlyn
    Urban, Nicole
    Taniguchi, Toshiyasu
    CANCER RESEARCH, 2008, 68 (08) : 2581 - 2586
  • [3] BRCA1 methylation and BRCA1 mutations in ovarian cancer
    Bol, Guus Martinus
    van Diest, Paul Joannes
    GYNECOLOGIC ONCOLOGY, 2011, 122 (02) : 459 - 459
  • [4] Breast and/or ovarian cancer in BRCA1/2 mutations carriers
    Bianchi, F.
    Rosati, S.
    Giorgetti, G.
    Galizia, E.
    Ferretti, C.
    Loretelli, C.
    Belvederesi, L.
    Catalani, R.
    Gagliardini, D.
    Bracci, R.
    Santinelli, A.
    Cellerino, R.
    ANNALS OF ONCOLOGY, 2006, 17 : XI26 - XI26
  • [5] Secondary BRCA1/2 mutations are associated with platinum resistance in BRCA1/2-mutated ovarian carcinomas
    Norguist, B.
    Taniguchi, T.
    Wurz, K.
    Karlan, B.
    Villegas, E.
    Sakai, W.
    Swisher, E.
    GYNECOLOGIC ONCOLOGY, 2010, 116 (03) : 594 - 594
  • [6] Contribution of BRCA1 and BRCA2 mutations to breast and ovarian cancer in Pakistan
    Liede, A
    Malik, IA
    Aziz, Z
    de los Rios, P
    Kwan, E
    Narod, SA
    AMERICAN JOURNAL OF HUMAN GENETICS, 2002, 71 (03) : 595 - 606
  • [7] Hereditary breast and ovarian cancer due to mutations in BRCA1 and BRCA2
    Petrucelli, Nancie
    Daly, Mary B.
    Feldman, Gerald L.
    GENETICS IN MEDICINE, 2010, 12 (05) : 245 - 259
  • [8] BRCA1 and BRCA2 mutations in Belgian families with a history of breast and/or ovarian
    Sibille-Hoang, C
    Froment, O
    de ter Beerst, AJ
    Lepiece, V
    Huberlant, G
    Blauwaert, G
    Vindevoghel, A
    Canon, JL
    Gillerot, Y
    EUROPEAN JOURNAL OF CANCER PREVENTION, 1998, 7 : S3 - S5
  • [9] P53 mutations in breast and ovarian carcinomas from BRCA1 and 2 mutation carriers and noncarriers
    E Sensi
    C Ghimenti
    G Cipollini
    D Iandolo
    G Naccarato
    P Viacava
    G Bevilacqua
    MA Caligo
    Breast Cancer Research, 2 (Suppl 1)
  • [10] Breast carcinomas arising in carriers of mutations in BRCA1 or BRCA2:: Are they prognostically different?
    Phillips, KA
    Andrulis, IL
    Goodwin, PJ
    JOURNAL OF CLINICAL ONCOLOGY, 1999, 17 (11) : 3653 - 3663